ad image

IssueQ22017

1 / 2
Biopharmaceutical Manufacturing Goes Mainstream
CDMO

Biopharmaceutical Manufacturing Goes Mainstream

Steve Kuehn; Cynthia A. Challener, Ph.D.; Emilie Branch

Nice Insight

PAP-Q2-17-FA-004Jun 29, 2017
The Road to Biologics’ Continued Success
Biologics

The Road to Biologics’ Continued Success

Nigel Walker; Steve Kuehn

Nice Insight

PAP-Q2-17-EN-001Jun 05, 2017
Biologics: Driving Force in Pharma
Biologics

Biologics: Driving Force in Pharma

Nigel Walker

Nice Insight

PAP-Q2-17-NO-001Jun 05, 2017
Making Real-Time Process Analytical Technology In Biomanufacturing A Reality
Process Analytical Technology

Making Real-Time Process Analytical Technology In Biomanufacturing A Reality

Clint Pepper, Ph.D.

Capsugel (Lonza)

PAP-Q2-17-IL-001Jun 05, 2017
Disease-In-A-Dish: Leveraging in vitro Human Models to Advance Drug Discovery
Drug Discovery

Disease-In-A-Dish: Leveraging in vitro Human Models to Advance Drug Discovery

Paul R. August; Mark J. Pincus, M.S.

Icagen

PAP-Q2-17-CL-006-5426Jun 05, 2017
Speeding Development and Reducing Costs with Analytical Quality by Design
Quality by Design

Speeding Development and Reducing Costs with Analytical Quality by Design

António Ramos; Rui Loureiro

Hovione

PAP-Q2-17-CL-006Jun 05, 2017
Implications of Serialization for the U.S. Pharma Industry
Regulatory

Implications of Serialization for the U.S. Pharma Industry

Walter C. Holberg III; Lee Murtagh

Alcami

PAP-Q2-17-CL-001Jun 05, 2017
Serialization: The First Steps In Sales Unit Traceability and Data Management
Regulation

Serialization: The First Steps In Sales Unit Traceability and Data Management

Michael Kinsella

Servier

PAP-Q2-17-CL-002Jun 05, 2017
Supporting the Tech Transfer Continuum for Cell & Gene Therapies
CDMO

Supporting the Tech Transfer Continuum for Cell & Gene Therapies

Richard Snyder, Ph.D.; Matthew Caple; Jessica Tate, Ph.D.

Thermo Fisher Scientific

PAP-Q2-17-CL-003Jun 05, 2017
Propagating a Full Spectrum of Services for ADC Development and Manufacture
Biologics

Propagating a Full Spectrum of Services for ADC Development and Manufacture

John Manzello; Campbell Bunce

Abzena

PAP-Q2-17-CL-007Jun 05, 2017
Moving Quality to the Forefront Brings Measurable Results
Regulatory

Moving Quality to the Forefront Brings Measurable Results

Chris Curtin

UPM Pharmaceuticals

PAP-Q2-17-CL-008Jun 05, 2017
Making Strides: Biologics Push Forward
Biologics

Making Strides: Biologics Push Forward

Steve Kuehn; Cynthia A. Challener, Ph.D.; Emilie Branch

Nice Insight

PAP-Q2-17-FA-001Jun 05, 2017
Clinical Trials Find a Device for Growth

Clinical Trials Find a Device for Growth

Steve Kuehn; Cynthia A. Challener, Ph.D.; Emilie Branch

Nice Insight

PAP-Q2-17-FA-002Jun 05, 2017
The Search for Alternative Delivery Methods Continues

The Search for Alternative Delivery Methods Continues

Steve Kuehn; Cynthia A. Challener, Ph.D.; Emilie Branch

Nice Insight

PAP-Q2-17-FA-003Jun 05, 2017
From Blobs to Hearts: Understanding the 3D Bioprinting Revolution
Innovation

From Blobs to Hearts: Understanding the 3D Bioprinting Revolution

Emilie Branch

Pharma's Almanac

PAP-Q2-17-TT-001Jun 05, 2017
Small Molecule Injectable Manufacturing: Challenges and Complexities
API

Small Molecule Injectable Manufacturing: Challenges and Complexities

Marga Viñes

Grifols

PAP-Q2-17-CL-013Jun 05, 2017
Building a One-Stop Shop CDMO for Biopharmaceuticals
CDMO

Building a One-Stop Shop CDMO for Biopharmaceuticals

Federico Pollano

Rentschler Biopharma SE

PAP-Q2-17-CL-012Jun 05, 2017
The People’s Choice: Premeasured Single Dosage Forms
Drug Delivery

The People’s Choice: Premeasured Single Dosage Forms

Rao Tatapudy, R.Ph., Ph.D.; David Kudla

Unither Pharmaceuticals

PAP-Q2-17-CL-014Jun 05, 2017
Design of Complex Biopharmaceutical Facilities: Considering Options and Alternatives
Equipment

Design of Complex Biopharmaceutical Facilities: Considering Options and Alternatives

Sue Behrens, Ph.D.; Tom Piombino, P.E.

IPS-Integrated Project Services, LLC

PAP-Q2-17-CL-011Jun 05, 2017
Designing Flexibility for Added Value
Innovation

Designing Flexibility for Added Value

Peter Cramer

Exyte

PAP-Q2-17-CL-015Jun 05, 2017
1 / 2